Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 21, 2018Nature CommunicationsOpen Access

Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMichael RuschSt. Jude Children's Research HospitalJNJoy NakitandweCleveland ClinicSSSheila ShurtleffCleveland Clinic

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rusch et al. (2018) studied this question.

synapsesocial.com/papers/6a737074f9fb99ee2c5665dbhttps://doi.org/10.1038/s41467-018-06485-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care2016 · 91 citations
  2. 2DNMT3A Mutations in Acute Myeloid Leukemia2010 · 2,005 citations
  3. 3BreakFusion: targeted assembly-based identification of gene fusions in whole transcriptome paired-end sequencing data2012 · 59 citations
  4. 4A Pilot Study Using Next-Generation Sequencing in Advanced Cancers: Feasibility and Challenges2013 · 32 citations